Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$226K Sell
3,149
-24,443
-89% -$2.3M 0.06% 45
2026
Q1
$3.26M Buy
27,592
+1,830
+7% +$226K 0.85% 41
2025
Q4
$3.24M Sell
25,762
-19,920
-44% -$2.6M 0.81% 41
2025
Q3
$6.68M Buy
45,682
+4,443
+11% +$672K 1.62% 20
2025
Q2
$6.43M Buy
41,239
+20,268
+97% +$3.21M 1.6% 19
2025
Q1
$3.45M Buy
+20,971
New +$3.49M 0.92% 38

Other funds holding ZTS

Davis Rea's ZTS Position: Q2 2026 in Review

Davis Rea reduced its Zoetis (ZTS) stake by 89% in Q2 2026, selling an estimated $2.3M and leaving 3,149 shares worth $226K. The position accounts for 0.06% of the portfolio, ranked #45.

Davis Rea first reported a position in ZTS in Q1 2025 and has held it in 6 quarters since. The position peaked at $6.68M in Q3 2025. 1,428 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Davis Rea held 3,149 shares of Zoetis worth $226K as of Q2 2026.
  • Davis Rea sold 24,443 Zoetis shares in Q2 2026, an estimated $2.3M.
  • Zoetis made up 0.06% of Davis Rea's portfolio in Q2 2026, its #45 holding.
  • Davis Rea first reported a position in Zoetis in Q1 2025 and has held it in 6 quarters since.
  • Davis Rea's Zoetis position peaked at $6.68M in Q3 2025.
  • 1,428 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Davis Rea's 13F filing for Q2 2026, filed 4 Aug 2026.